DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Acura Pharmaceuticals Q2 EPS $(0.15) Down From $(0.06) YoY, Sales $46K May Not Compare To $92K Estimate

Acura Pharmaceuticals (NASDAQ:ACUR) reported quarterly losses of $(0.15) per share. This is a 150 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of

Benzinga · 02/10/2020 21:31

Acura Pharmaceuticals (NASDAQ:ACUR) reported quarterly losses of $(0.15) per share. This is a 150 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $46 thousand which missed the analyst consensus estimate of $92 thousand by 50.00 percent. This is a 39.47 percent decrease over sales of $76 thousand the same period last year.